LianBio Profile Avatar - Palmy Investing

LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treat…

Biotechnology
US, Princeton [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

LianBio can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

LianBio can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of LianBio.

If you want to see a demo, head over to the financial segments of AAPL

End of LIAN's Analysis
CIK: 1831283 CUSIP: - ISIN: US53000N1081 LEI: - UEI: -
Secondary Listings
LIAN has no secondary listings inside our databases.